article thumbnail

Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

Cannabis Law Report

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally.

article thumbnail

Radicle Science and Open Book Extracts Announce New Alliance to Advance Consumer Trust and CBD Industry Validation

Cannabis Law Report

Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK Parliament Finds A Few Moments To Discuss Medical Cannabis & Emma Appleby Affair In Between Brexit Chaos

Cannabis Law Report

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

article thumbnail

Ukraine Cabinet Backs Bill To Legalize Medical Cannabis (7 June 2022)

Cannabis Law Report

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “; 6) Article 15 shall be worded as follows: “Article 15.

article thumbnail

Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement

Cannabis Law Report

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. In October 2021, Virpax announced that a $1.87

article thumbnail

Virpax Pharmaceuticals Reports 2021 Third Quarter Results and Recent Developments

Cannabis Law Report

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Probudur™ is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain.

article thumbnail

How Mara Gordon Got Her Start in Cannabis

The Cannigma

All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I And I had been a serious chronic pain patient, plus some other issues after having spinal meningitis back in 1996. I know how to collect data. I know how to analyze data. How does that process work?